Today, Paxman publishes the February issue of its newsletter aimed at shareholders, investors and other interested parties.
This month’s issue highlights that Paxman has launched a digital library website with a wealth of scalp cooling clinical research studies and data. The Scalp Cooling Study Library is a comprehensive database which unites key published clinical research studies and data, providing an independent overview of global research and practice on scalp cooling and cryotherapy for managing the often devastating side effects of chemotherapy induced hair loss and peripheral neuropathy. The website explores the latest in scalp cooling clinical data, randomized controlled trials, multi-center studies and scientific research and hosts over 60 scalp cooling and cryocompression research studies so far.
The newsletter also includes information on Paxman’s new distribution agreement with a partner in Colombia, a new upcoming clinical study by Paxman and Montefiore Medical Center, the University Hospital for Albert Einstein College of Medicine in New York City to evaluate scalp cooling for chemotherapy-induced alopecia in patients of colour in the United States, as well as many new orders and installs in the US, the UK, Russia, Australia, Turkey and a French island off Madagascar.
To read the newsletter and subscribe for upcoming issues, follow this link:
Paxman’s investor newsletter is published monthly as a part of the company’s effort to strengthen its market communication together with the IR communication agency Honeybadger. Every published issue of the newsletter is available on Paxman’s website for investors, www.paxman.se. The company encourages feedback and requests on topics for upcoming issues of the newsletter.
